Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

B-Cell CLL/lymphoma 2 (BCL2) (Middle Region) Peptide

BCL2 Reactivity: Human Host: Synthetic BP, WB
Catalog No. ABIN973780
  • Target See all Bcl-2 (BCL2) products
    Bcl-2 (BCL2) (B-Cell CLL/lymphoma 2 (BCL2))
    Protein Region
    Middle Region
    Origin
    Human
    Source
    • 12
    Synthetic
    Application
    Blocking Peptide (BP), Western Blotting (WB)
    Sequence
    ALSPVPPVVH LTLRQAGDDF SRRYRRDFAE MSSQLHLTPF TARGRFATVV
    Characteristics
    This is a synthetic peptide designed for use in combination with anti-BCL2 Antibody(ARP58872_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
    Purification
    Purified
  • Application Notes
    Each Investigator should determine their own optimal working dilution for specific applications.
    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Reconstitution
    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
    Concentration
    1 mg/mL
    Buffer
    Final peptide concentration is 1 mg/mL in PBS.
    Handling Advice
    Avoid repeated freeze-thaw cycles.
    Storage
    -20 °C
    Storage Comment
    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target
    Bcl-2 (BCL2) (B-Cell CLL/lymphoma 2 (BCL2))
    Synonyms
    Bcl-2 Peptide, PPP1R50 Peptide, bcl-2 Peptide, AW986256 Peptide, C430015F12Rik Peptide, D630044D05Rik Peptide, D830018M01Rik Peptide, BCL-2 Peptide, Bcl2 Peptide, BCL2, apoptosis regulator Peptide, B cell leukemia/lymphoma 2 Peptide, B-cell CLL/lymphoma 2a Peptide, B-cell CLL/lymphoma 2 protein Peptide, BCL2 Peptide, Bcl2 Peptide, bcl2a Peptide, BCL-2 Peptide
    Background
    This gene encodes an integral outer mitochondrial membrane protein that blocks the apoptotic death of some cells such as lymphocytes. Constitutive expression of BCL2, such as in the case of translocation of BCL2 to Ig heavy chain locus, is thought to be the cause of follicular lymphoma. Two transcript variants, produced by alternate splicing, differ in their C-terminal ends.

    Alias Symbols: Bcl-2, PPP1R50

    Protein Interaction Partner: BAD,BAD,BAX,BBC3,BCL2L11,BID,BIK,BIK,BMF,BNIPL,HRK,HRK,RHEB,MOAP1,ATP2A2,BAD,BAG1,BAG3,BAG4,BAK1,BAX,BBC3,BCAP31,BCL2,BCL2L1,BCL2L10,BCL2L11,BCL2L14,BCLAF1,BECN1,BFAR,BID,BIK,BLK,BMF,BNIP1,BNIP2,BNIP3,BNIP3L,BNIPL,CASP3,CASP8,CDK2,CPT1A,CYCS,FKBP8,HRAS,HR

    Protein Size: 239
    Molecular Weight
    26 kDa
    Gene ID
    596
    NCBI Accession
    NM_000633, NP_000624
    UniProt
    P10415
You are here:
Support